AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas –immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on X, Facebook, Instagram, YouTube, LinkedIn and Tik Tok.

1 North Waukegan Road
North Chicago, IL 60064

Visit website

Stock Symbol: ABBV
Stock Exchange: NYSE

Together, we break through.

Our principles are at the Heart of our Company. Operating as one AbbVie team, we care deeply for our patients, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. In everything we do, we invest and innovate relentlessly to tackle unmet needs, creating new medicines and healthcare approaches for a healthier world.

How we work with each other and achieve results matters. That’s why we’ve been honored to receive some of the most prestigious ratings and recognitions in the industry, including being named on more than 40 Great Place to Work and Top Employer lists and FORTUNE “100 Best Companies to Work For.”

Click here to learn more about our principles.

NEWS

Bio NC

Clinical Catch-Up: May 11-15

Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here’s a look.

May 15, 2020

12 min read

Mark Terry

Drug Development

Biopharma Update on the Novel Coronavirus: May 11

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.

May 11, 2020

4 min read

BioSpace Editorial Staff

Deals

One Step Closer: FTC Clears AbbVie and Allergan’s $63 Billion Merger

The U.S. Federal Trade Commission gave the green light to the $63 billion merger of AbbVie and Allergan. That leaves one last hurdle for the two companies, approval from the Irish High Court.

May 6, 2020

2 min read

Alex Keown

Job Trends

Clinical Catch-Up: April 20-24

Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look.

April 24, 2020

10 min read

Mark Terry

FDA

Imbruvica-Rituximab Combo Approved by FDA for Chronic Lymphocytic Leukemia

The FDA recently approved the combination of Imbruvica-Rituximab for treating chronic lymphocytic leukemia. Here’s everything you need to know.

April 22, 2020

2 min read

Mark Terry

Insight Report: HIV and AIDS Research and Treatments

BioSpace takes an in-depth look at the human immunodeficiency virus including research, drugs in the pipeline and treatments. Check out the free downloadable report.

April 20, 2020

4 min read

Chelsea Weidman Burke, M.S.

Genetown

Genetown Hotbed: Churning Along During the COVID-19 Pandemic

As the biopharma industry responds to the COVID-19 pandemic, some of the area’s companies are at the very frontlines of drug development against the disease, while others play supporting roles for the entire industry. Here’s a look.

March 31, 2020

6 min read

Mark Terry